Research Articles | Page 6 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes Jun 2025 American Society of Clinical Oncology Educational Book Myelodysplastic Syndromes (MDS)
Baseline Clinical Characteristics and Disease Burden in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis From the International PNH Registry Jul 2020 Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia Sep 2024 Annals of Hematology Aplastic Anemia
Initial management of patients with acquired aplastic anemia in the United States: results from a large national claims database Apr 2025 Annals of Hematology Aplastic Anemia
Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists Nov 2024 Annals of Hematology Myelodysplastic Syndromes (MDS)
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria Oct 2023 Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria? May 2025 Annals of Hematology Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH)
Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series Jan 2021 Annals of Hematology Aplastic Anemia
Evolving therapies for lower-risk myelodysplastic syndromes Apr 2020 Annals of Hematology Myelodysplastic Syndromes (MDS)
Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies Jun 2025 Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)